Non-cystic Fibrosis Bronchiectasis

Overview

Journal Clin Med (Lond)

Specialty General Medicine

Date 2009 May 14

PMID 19435127

Citations 5

Authors

Maeve P Murray

Adam T Hill

Affiliations

Soon will be listed here.

Citing Articles

Factors Associated With Multi-Drug Resistant Organisms Among Bronchiectasis Patients: A Retrospective Study of Bronchiectasis Patients in Jordan.

Al Oweidat K, Toubasi A, Khraisat F, Al-Sayegh T, Al-Harasis L, Albtoosh A Int J Gen Med. 2025; 18:391-402.

PMID: 39881954 PMC: 11776428. DOI: 10.2147/IJGM.S490196.

Chest X-Ray Features in 130 Patients with Bronchiectasis.

Sawada H, Kudoh R, Yokoyama A, Hagiwara A, Hiramatsu K, Kadota J Diseases. 2024; 12(12.

PMID: 39727653 PMC: 11726920. DOI: 10.3390/diseases12120323.

A systematic literature review of the clinical and socioeconomic burden of bronchiectasis.

Chalmers J, Mall M, McShane P, Nielsen K, Shteinberg M, Sullivan S Eur Respir Rev. 2024; 33(173).

PMID: 39231597 PMC: 11372470. DOI: 10.1183/16000617.0049-2024.

The diagnostic utility of microscopic quality assessment of sputum samples in the era of rapid syndromic PCR testing.

Lunde Markussen D, Ebbesen M, Serigstad S, Knoop S, Ritz C, Bjorneklett R Microbiol Spectr. 2023; :e0300223.

PMID: 37772853 PMC: 10581175. DOI: 10.1128/spectrum.03002-23.

The effect of azithromycin on sputum inflammatory markers in bronchiectasis.

Terpstra L, Altenburg J, Doodeman H, Pineros Y, Lutter R, Heijerman H BMC Pulm Med. 2023; 23(1):151.

PMID: 37118704 PMC: 10148509. DOI: 10.1186/s12890-023-02444-1.

References

Thompson C, Harrison S, Ashley J, Day K, Smith D . Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax. 2002; 57(5):446-8. PMC: 1746316. DOI: 10.1136/thorax.57.5.446. View

Martinez-Garcia M, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna J . Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respir Med. 2006; 100(9):1623-32. DOI: 10.1016/j.rmed.2005.12.002. View

Angrill J, Agusti C, De Celis R, Rano A, Gonzalez J, Sole T . Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax. 2002; 57(1):15-9. PMC: 1746176. DOI: 10.1136/thorax.57.1.15. View

Murray M, Turnbull K, MacQuarrie S, Hill A . Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur Respir J. 2008; 33(2):312-8. DOI: 10.1183/09031936.00122508. View

Davies G, Wells A, Doffman S, Watanabe S, Wilson R . The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J. 2006; 28(5):974-9. DOI: 10.1183/09031936.06.00074605. View

Sheikh A, Nolan D, Greenstone M . Long-acting beta-2-agonists for bronchiectasis. Cochrane Database Syst Rev. 2001; (4):CD002155. PMC: 8407186. DOI: 10.1002/14651858.CD002155. View

King P, Holdsworth S, Freezer N, Villanueva E, Holmes P . Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006; 100(12):2183-9. DOI: 10.1016/j.rmed.2006.03.012. View

Patterson J, Bradley J, Hewitt O, Bradbury I, Elborn J . Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus Acapella. Respiration. 2005; 72(3):239-42. DOI: 10.1159/000085363. View

Currie D, Garbett N, Chan K, Higgs E, Todd H, Chadwick M . Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. Q J Med. 1990; 76(280):799-816. View

10.

Barker A, Couch L, Fiel S, Gotfried M, Ilowite J, Meyer K . Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med. 2000; 162(2 Pt 1):481-5. DOI: 10.1164/ajrccm.162.2.9910086. View

11.

Tsang K, Chan W, Ho P, Chan K, Lam W, Ip M . A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. Eur Respir J. 1999; 14(5):1206-9. DOI: 10.1183/09031936.99.14512069. View

12.

Kellett F, Redfern J, Niven R . Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med. 2005; 99(1):27-31. DOI: 10.1016/j.rmed.2004.05.006. View

13.

Franco F, Sheikh A, Greenstone M . Short acting beta-2 agonists for bronchiectasis. Cochrane Database Syst Rev. 2003; (3):CD003572. DOI: 10.1002/14651858.CD003572. View

14.

Twiss J, Metcalfe R, Edwards E, Byrnes C . New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child. 2005; 90(7):737-40. PMC: 1720490. DOI: 10.1136/adc.2004.066472. View

15.

. PROLONGED antibiotic treatment of severe bronchiectasis; a report by a subcommittee of the Antibiotics Clinical Trials (non-tuberculous) Committee of the Medical Research Council. Br Med J. 1957; 2(5039):255-9. PMC: 1961737. View

16.

Nicotra M, Rivera M, Dale A, Shepherd R, Carter R . Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 1995; 108(4):955-61. DOI: 10.1378/chest.108.4.955. View

17.

Elborn J, Johnston B, Allen F, Clarke J, McGarry J, Varghese G . Inhaled steroids in patients with bronchiectasis. Respir Med. 1992; 86(2):121-4. DOI: 10.1016/s0954-6111(06)80227-1. View

18.

Drobnic M, Sune P, Montoro J, Ferrer A, Orriols R . Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother. 2004; 39(1):39-44. DOI: 10.1345/aph.1E099. View

19.

Naidich D, McCauley D, Khouri N, Stitik F, Siegelman S . Computed tomography of bronchiectasis. J Comput Assist Tomogr. 1982; 6(3):437-44. DOI: 10.1097/00004728-198206000-00001. View

20.

Orriols R, Roig J, Ferrer J, Sampol G, Rosell A, Ferrer A . Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med. 1999; 93(7):476-80. DOI: 10.1016/s0954-6111(99)90090-2. View